Evidence map›Paper›PMID 39231970›Full record

ArticleCell death & disease2024

Correction: YOD1 protects against MRSA sepsis-induced DIC through Lys33-linked deubiquitination of NLRP3.

Chang Liu, Caihong Fan, Jia Liu, Shiqi Zhang, Huixin Tang, Yashan Liu, Shengzheng Zhang, Qiang Wu, Jiandong Zhang, Zhi Qi and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Chang Liu *School of Medical Technology, Tianjin Medical University, Tianjin, China.
Caihong Fan *School of Medical Technology, Tianjin Medical University, Tianjin, China.
Jia Liu *School of Medical Technology, Tianjin Medical University, Tianjin, China.
Shiqi ZhangSchool of Medical Technology, Tianjin Medical University, Tianjin, China.
Huixin TangSchool of Medical Technology, Tianjin Medical University, Tianjin, China.
Yashan LiuSchool of Medical Technology, Tianjin Medical University, Tianjin, China.
Shengzheng ZhangDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, China.
Qiang WuKey Laboratory of Emergency and Trauma of Ministry of Education, Hainan Medical University, Haikou, China.
Jiandong ZhangThe Third Central Hospital of Tianjin, Tianjin, China.
Zhi QiDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, China. qizhi@nankai.edu.cn.
Yanna ShenSchool of Medical Technology, Tianjin Medical University, Tianjin, China. shenyanna@tmu.edu.cn.ORCID http://orcid.org/0000-0001-5643-1916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39231970
PMCPMC11374977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.